go 6976 has been researched along with Carcinoma, Transitional Cell in 3 studies
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aaltonen, V | 3 |
Peltonen, J | 3 |
Koivunen, J | 1 |
Koskela, S | 2 |
Lehenkari, P | 2 |
Laato, M | 1 |
Leinonen, P | 1 |
Korkiamäki, T | 1 |
3 other studies available for go 6976 and Carcinoma, Transitional Cell
Article | Year |
---|---|
PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.
Topics: Carbazoles; Carcinoma, Transitional Cell; Cell Line, Tumor; Flow Cytometry; G1 Phase; Genes, p53; Hu | 2010 |
Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells.
Topics: Actins; Adherens Junctions; Carbazoles; Carcinoma, Transitional Cell; Cell Movement; Cytoskeleton; D | 2004 |
Impaired gap junction formation and intercellular calcium signaling in urinary bladder cancer cells can be improved by Gö6976.
Topics: Blotting, Western; Calcium Signaling; Carbazoles; Carcinoma, Transitional Cell; Cell Communication; | 2007 |